SIRT With Tremelimumab and Durvalumab for Resectable HCC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Hepatocellular Carcinoma
Related studies linked through entity extraction aliases.
GastroIntestinal Cancer in Children and Adolescents
- Status
- UNKNOWN
- Phase
- N/A
Non-contrast Abbreviated MRI for Secondary Surveillance of HCC
- Status
- COMPLETED
- Phase
- N/A
Single Centre Prospective Evaluation of 68Gallium-FAPI PET/MRI in Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE1
Replicor Compassionate Access Program
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Therapeutic Assistance and Decision-making Algorithms in Hepatobiliary Tumor Boards
- Status
- UNKNOWN
- Phase
- NA
Oncolytic Virotherapy Plus PD-1 Inhibitor and Lenvatinib as Second-line or Later Therapy in Patients With Advanced Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE1
Effects of Esketamine on Acute Abdominal Pain After TACE in Patients With Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE4
AD HOC Trial: Artificial Intelligence-Based Drug Dosing In Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
GNB4 and Riplet Gene Methylation Combined Detection Kit (Fluorescence PCR Method)
- Status
- UNKNOWN
- Phase
- N/A
Radiofrequency Ablation for Hepatocellular Carcinoma Using Octopus MP Electrodes
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
FAPI PET for Response Evaluation and Prognosis Prediction in Liver and Biliary Cancer Patients Treated With PD-1 Combination Therapy
- Status
- UNKNOWN
- Phase
- N/A
Alternative Surveillance Program for Patients With High Risk Group of HCC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Ori-C101Chimeric Antigen Receptor (CAR) Modified T Cells for the Treatment of HCC
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Peri-operative Vitamin D Therapy for Hepatectomy
- Status
- UNKNOWN
- Phase
- NA
Safety and Feasibility of Radioembolization Using Ho-166 in Patients With Unresectable Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- NA
Safety and Effectiveness of BioTraceIO 360 for Planning, Monitoring and Assessment of Liver Tissue Ablation Procedures (PANORAMA2)
- Status
- WITHDRAWN
- Phase
- NA
Study of [18F]FAPI-74 PET in Patients With Gastrointestinal Cancers
- Status
- COMPLETED
- Phase
- PHASE2
Effect of Nutritional Indices on the Prognosis of HCC Patients
- Status
- COMPLETED
- Phase
- N/A
Lipiodol-TACE With Idarubicin Based On a Specific Emulsion Ratio for Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- N/A